Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
-64.6%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.02 | +390.3% |
| 2024 | 0.00 | +105.8% |
| 2023 | -0.08 | -115.6% |
| 2022 | 0.53 | - |